| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.22 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |